Adrian Adams has resigned as the CEO and board member of Marlborough, MA-based drug maker Sepracor (NASDAQ:[[ticker:SEPR]]), according to the company and Japan’s Dainippon Sumitomo Pharma (DSP), which is buying Sepracor. Saburo Hamanaka has become chairman of Sepracor and executive officer of Dainippon. Dainippon, which announced its $2.6 billion buyout of Sepracor in September 2009, says that the merger of Sepracor and its subsidiary, Dainippon Sumitomo Pharma America, is expected to wrap up on April 1.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
